clarifying the BPC 157 TB 500 FDA situation since it's getting garbled in basically every thread : r Biohackers Peptides: Legal and Regulatory Risks 503A Compounding Pharmacies Must Understand This is one of the biggest peptide regulatory updates in years, and it's just the beginning. The FDA has officially initiated the first step to reverse its 2023 stance, removing 12 peptides Peptides are starting to move back into the conversation., After years of restriction under the FDAs 503A Category 2 list, were now seeing momentum toward re evaluation and potential reintroduction